These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1500269)

  • 1. Bis-daunomycin hydrazones: interactions with DNA.
    Phillips DR; Brownlee RT; Reiss JA; Scourides PA
    Invest New Drugs; 1992 Jul; 10(2):79-88. PubMed ID: 1500269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The synthesis, stability and biological activity of bis-intercalating bis-daunomycin hydrazones.
    Phillips DR; Baguley BC; Brownlee RT; Cacioli P; Chandler CJ; Kyratzis I; Reiss JA; Scourides PA
    Drug Des Deliv; 1990 Mar; 5(3):203-19. PubMed ID: 1670502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of polyamine-linked bis-daunomycin hydrazones and their interaction with DNA.
    Hook RJ; Phillips DR; Reiss JA
    Anticancer Drug Des; 1989 Oct; 4(3):173-90. PubMed ID: 2803466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidation of the DNA sequence preferences of daunomycin.
    Skorobogaty A; White RJ; Phillips DR; Reiss JA
    Drug Des Deliv; 1988 Jul; 3(2):125-51. PubMed ID: 2855576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploiting anthracycline scaffold for designing DNA-targeting agents.
    Priebe W; Fokt I; Przewloka T; Chaires JB; Portugal J; Trent JO
    Methods Enzymol; 2001; 340():529-55. PubMed ID: 11494869
    [No Abstract]   [Full Text] [Related]  

  • 6. Kinetics and sequence specificity of drug-DNA interactions: an in vitro transcription assay.
    Phillips DR; Crothers DM
    Biochemistry; 1986 Nov; 25(23):7355-62. PubMed ID: 3801418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The DNA-association and biological activity of a new bis(14-thiadaunomycin).
    Skorobogaty A; Brownlee RT; Chandler CJ; Kyratzis I; Phillips DR; Reiss JA; Trist H
    Anticancer Drug Des; 1988 Jun; 3(1):41-56. PubMed ID: 3382506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA binding and antigene activity of a daunomycin-conjugated triplex-forming oligonucleotide targeting the P2 promoter of the human c-myc gene.
    Carbone GM; McGuffie E; Napoli S; Flanagan CE; Dembech C; Negri U; Arcamone F; Capobianco ML; Catapano CV
    Nucleic Acids Res; 2004; 32(8):2396-410. PubMed ID: 15121897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daunomycin, an antitumor DNA intercalator, influences histone-DNA interactions.
    Wójcik K; Zarębski M; Cossarizza A; Dobrucki JW
    Cancer Biol Ther; 2013 Sep; 14(9):823-32. PubMed ID: 23792590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisanthracycline WP631 inhibits basal and Sp1-activated transcription initiation in vitro.
    Martín B; Vaquero A; Priebe W; Portugal J
    Nucleic Acids Res; 1999 Sep; 27(17):3402-9. PubMed ID: 10446226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biophysical chemistry of the daunomycin-DNA interaction.
    Chaires JB
    Biophys Chem; 1990 Apr; 35(2-3):191-202. PubMed ID: 2204442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential binding of daunomycin to 5'ATCG and 5'ATGC sequences revealed by footprinting titration experiments.
    Chaires JB; Herrera JE; Waring MJ
    Biochemistry; 1990 Jul; 29(26):6145-53. PubMed ID: 2207063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multistep drug intercalation: molecular dynamics and free energy studies of the binding of daunomycin to DNA.
    Wilhelm M; Mukherjee A; Bouvier B; Zakrzewska K; Hynes JT; Lavery R
    J Am Chem Soc; 2012 May; 134(20):8588-96. PubMed ID: 22548344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new bisintercalating anthracycline with picomolar DNA binding affinity.
    Portugal J; Cashman DJ; Trent JO; Ferrer-Miralles N; Przewloka T; Fokt I; Priebe W; Chaires JB
    J Med Chem; 2005 Dec; 48(26):8209-19. PubMed ID: 16366602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymerase-chain reaction as a tool for investigations on sequence-selectivity of DNA-drugs interactions.
    Passadore M; Feriotto G; Bianchi N; Aguiari G; Mischiati C; Piva R; Gambari R
    J Biochem Biophys Methods; 1994 Dec; 29(3-4):307-19. PubMed ID: 7699207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intercalation of daunomycin into stacked DNA base pairs. DFT study of an anticancer drug.
    Barone G; Guerra CF; Gambino N; Silvestri A; Lauria A; Almerico AM; Bickelhaupt FM
    J Biomol Struct Dyn; 2008 Aug; 26(1):115-30. PubMed ID: 18533732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daunomycin intercalation stabilizes distinct backbone conformations of DNA.
    Trieb M; Rauch C; Wellenzohn B; Wibowo F; Loerting T; Mayer E; Liedl KR
    J Biomol Struct Dyn; 2004 Apr; 21(5):713-24. PubMed ID: 14769064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daunomycin binding to detergent micelles: a model system for evaluating the hydrophobic contribution to drug-DNA interactions.
    Dignam JD; Qu X; Ren J; Chaires JB
    J Phys Chem B; 2007 Oct; 111(39):11576-84. PubMed ID: 17845023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorinated anthracyclines: synthesis and biological activity.
    Tonkin KC; Brownlee RT; Zunino F; Phillips DR
    Invest New Drugs; 1990 Feb; 8(1):1-6. PubMed ID: 2345065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of DNA binding, DNA cleavage, protein binding and in vitro cytotoxic activities of bivalent transition metal hydrazone complexes.
    Krishnamoorthy P; Sathyadevi P; Cowley AH; Butorac RR; Dharmaraj N
    Eur J Med Chem; 2011 Aug; 46(8):3376-87. PubMed ID: 21600679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.